A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Point-of-care ultrasound (POCUS) is often used to assess the hemodynamic circuit and detect the presence of venous congestion. The Venous Excess Ultrasound (VExUS) scoring system was developed to aid clinicians in predicting the impact of venous congestion on organ dysfunction. This article aims to describe VExUS image acquisition and interpretation.
Providers in many medical specialties must accurately assess the hemodynamic circuit to deliver appropriate patient care. Venous congestion is increasingly implicated in a range of multiorgan complications. However, hemodynamic assessment remains challenging because of the complex physiology involved and inconsistent diagnostic accuracy of conventional bedside tools and physical exam maneuvers. While right heart catheterization is regarded as the gold standard for measuring systemic venous pressure, it is invasive and not easily repeatable, and thus, there remains a need for non-invasive alternatives. Even point-of-care ultrasound examinations of the internal jugular vein or inferior vena cava have significant limitations in terms of accuracy of intravascular volume assessment and correlation with central venous pressure. To improve bedside clinicians' accuracy at assessing venous congestion, a protocol was developed and validated that utilizes pulsed-wave (PW) Doppler signals of veins in the liver and kidney to grade the degree of venous congestion present in patients. Although this scoring system, called Venous Excess Ultrasound (VExUS), is being increasingly adopted within certain subspecialties of medicine, such as nephrology and critical care, it remains underutilized in medicine as a whole. This is likely due, at least in part, to knowledge gaps and lack of training in this emerging modality. To address this educational gap, this article will describe VExUS image acquisition and interpretation.
Assessment of the hemodynamic circuit at the bedside is fundamental to the daily care of acutely ill patients. The deleterious effects of fluid overload are increasingly recognized even outside of more obvious clinical syndromes such as heart failure, and there are now multiple studies showing that positive fluid balance is associated with increased mortality1. There is a growing body of evidence that shows that even low levels of venous congestion are associated with organ dysfunction2. Similarly, timely decongestion is associated with improved outcomes3. This multiorgan, dynamic circuit involves the right and left heart, systemic vascular resistance, pulmonary artery pressures, and sequential right-sided venous return, culminating in the vena cava. It is complex, and its accurate assessment remains challenging for bedside clinicians. Clinicians from a variety of specialties make decisions regularly based on this assessment. Conventional bedside tools and physical exam maneuvers, including assessment of jugular venous pressure, are almost always available but remain unreliable4,5,6,7,8,9. Point of care ultrasound (POCUS) is a limited ultrasound examination performed at the bedside and is interpreted by the treating physician to answer focused clinical questions. It is integrated in real-time with the patient's history, physical examination, and other available data to aid in diagnosis and management. Over the last several years, ultrasound has solidified itself as an extension of the physical exam10, improving clinicians' ability to detect venous congestion11,12. Additionally, POCUS can guide decongestive therapy, which can potentially positively affect patient outcomes2,3.
One specific protocol using ultrasound that has been validated to help with hemodynamic assessment is the venous excess ultrasound score, or VExUS. First described by Beaubien-Souligny et al.13 in 2020, this scoring system was originally validated in post-cardiac surgery patients as a reliable predictor of acute kidney injury (AKI). Over the past several years, VExUS has also been shown to help with intravascular volume assessment in multiple other clinical contexts14,15,16,17. VExUS evaluates multiple intra-abdominal veins to screen for sonographic signs associated with congestion. These sonographic signs of congestion appear and progress in incremental fashion as venous congestion worsens, allowing VExUS to both screen for congestion and potentially track its response to therapy over time.
While the individual components of the VExUS exam have long been in use18,19,20, their combination, as well as their use to monitor therapy over time, remain underutilized, partly due to providers' lack of familiarity with how to perform the exam. We believe that this gap in knowledge is one major factor that has prevented wider-scale adoption of VExUS as the primary alternative to gold-standard invasive cardiac monitoring of venous pressures.
To attempt to address this knowledge gap, this article describes an instructional protocol for performing the VExUS exam, which can serve as a step-by-step guide for bedside clinicians. This protocol draws on the collective experience of a group of physicians representing multiple medical specialties (nephrology, critical care, internal medicine, and anesthesiology) from multiple academic medical centers to describe a standardized approach to VExUS image acquisition and interpretation.
All procedures performed in studies involving human participants adhered to the ethical standards of the institutional research committee and the Declaration of Helsinki, including its later amendments or comparable ethical standards. Written informed consent was obtained from the human participants. The scanning technique encompassed transducer selection, machine settings, patient positioning, B-mode scanning, and image acquisition. Patients with unclear volume status, suspected venous congestion, heart failure, acute kidney injury (AKI), and/or chronic kidney disease (CKD) were included in the study, while those with end-stage kidney disease on dialysis, known cirrhosis or portal vein thrombosis, or any condition preventing safe probe usage over the abdomen were excluded. The details of the reagents and equipment used are listed in the Table of Materials.
1. Transducer selection
2. Machine settings
3. Patient and sonographer positioning
4. Mode, presets, and setup
5. Inferior vena cava (IVC) imaging
6. Hepatic vein Doppler
7. Portal vein Doppler
8. Imaging of renal parenchymal veins
The first step to the VExUS exam involves imaging the inferior vena cava (IVC) to determine if there are signs of elevated right atrial pressures that would qualify the patient for the remainder of the exam. When imaging the IVC, it is important to view it from both the longitudinal and transverse perspectives to see the vessel in its maximal dimension. If the IVC is greater than 2 cm in its maximal anteroposterior diameter, then the remainder of the examination can be performed.
The next step...
Critical steps
VExUS was developed in post-cardiac surgery patients to quantify venous congestion non-invasively, but the utility has expanded for its use to assist in the evaluation of venous congestion and assessment of fluid status in multiple clinical contexts. To perform the exam properly, several critical steps must be considered. First, to maximize the diagnostic yield of the exam, one must consider the requirements of the VExUS exam when selecting a transducer and preset23. ...
YSB reports receiving honoraria from the American Society of Anesthesiologists for Editorial Board work on Point-of-Care Ultrasound and from OpenAnesthesia.org for creating educational content related to POCUS. The remaining authors have no disclosures.
None.
Name | Company | Catalog Number | Comments |
5500P Ultrasound System | Philips | HC795143 | Used to obtain a subset of the Figures and Videos |
Affiniti 70 Ultrasound System | Philips | HC795210 | Used to obtain a subset of the Figures and Videos |
Curvilinear Transducer (C1-5-D) | GE | 5409287-R | 1-5 MHz, also called the abdominal probe |
Curvilinear Transducer (C5-1) | Philips | HC989605412041 | 2-5 MHz, also called the abdominal probe |
Curvilinear Transducer (C5-1) | SonoSite | https://www.sonosite.com/products/ultrasound-transducers/c5-1 | 1-5 MHz, also called the abdominal probe |
Curvilinear Transducer (C5-2s) | Mindray | https://lysis.cc/products/mindray-c5-2s | 1-5 MHz, also called the abdominal probe |
Edge 1 Ultrasound Machine | SonoSite | Used to obtain a subset of the Figures and Videos | |
Handheld Probe (Butterfly iQ3) | Butterfly | https://www.butterflynetwork.com/iq3?srsltid=AfmBOorvY6WqHGbdeWW gtefztEJa8pt_xbwSOc6hQuB2s-Kb0wRlsCLR | Used to obtain a subset of the Figures and Videos |
LOGIQ P9 Ultrasound System | GE | H42752LS | Used to obtain a subset of the Figures and Videos |
Lumify Handheld Ultrasound | Philips | Used to obtain a subset of the Figures and Videos | |
Phased-Array Transducer (3Sc-D) | GE | https://services.gehealthcare.in/gehcstorefront/p/5863286 | 1-5 MHz, also called the cardiac probe |
Phased-Array Transducer (P4-2s) | Mindray | https://lysis.cc/products/mindray-p4-2s | 1-5 MHz, also called the cardiac probe |
Phased-Array Transducer (P5-1) | SonoSite | https://www.sonosite.com/in/products/ultrasound-transducers/p5-1 | 1-5 MHz, also called the cardiac probe |
Phased-Array Transducer (S4-1) | Philips | HC989605389271 | 1-5 MHz, also called the cardiac probe |
TE7 Max Ultrasound System | Mindray | https://www.mindray.com/na/products/ultrasound/point-of-care/te-series/te-7-max-portable-ultrasound-machine/ | Used to obtain a subset of the Figures and Videos |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved